Mitomycin-C shortage – information for UK patients.

On October 24th 2019, the Medicines and Healthcare products Regulatory Agency (MHRA) distributed a CAS Alert for Mitomycin-C regarding its supply and distribution. CAS is the Central Alerting System which cascades warnings regarding medicines and medical devices...

Announcing our Bereavement Support Group

Here at Pseudomyxoma Survivor, our focus is very much on surviving with pseudomyxoma peritonei (PMP) and appendix cancers. One group of our community who are surviving with PMP and appendix cancer are those that are surviving after the loss of a loved one to the...

Donate tissue sample – US patients

Calling US patients: Do you have an upcoming surgery or an ascites drain scheduled in the United States? If so, please consider donating your excess tissue for an important research project. The ACPMP Research Foundation has partnered with Pattern.org to enable...

Dr Paul Sugarbaker

Dr Paul Sugarbaker Director, Program in Peritoneal Surface Oncology Dr. Paul Hendrick Sugarbaker was born in Baltimore (Maryland, USA). His college education took place at Wheaton College in Illinois. He graduated from Cornell University Medical College in New York...

CRS and HIPEC sounds complicated, what is it?

Cytoreductive surgery (CRS) for pseudomyxoma peritonei (PMP) is a complex operation with the aim of removing all visible tumours, affected tissue and entire organs. The National Institute for Health and Care Excellence (NICE) guidelines¹ recommends the Sugarbaker...